Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
Reiter A, George TI, Engelbrecht ME, et al.
Nat Med · 2021
Key Findings
- ●EXPLORER phase 1: avapritinib safety and dose-finding in AdvSM
- ●Established recommended phase 2 dose
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: doi-10-1038-s41591-021-01538-9DOI: 10.1038/s41591-021-01538-9